Related Experiment Video
Updated: May 18, 2026
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
[Surgical tactics by various ameloblastic tumors]
Stomatologiia
|September 27, 2012
Summary
Ameloblastoma and ameloblastic fibroma are benign jaw tumors that can recur. Immunohistochemistry aids surgical planning, and in some cases, biopsy with bone margin resection is sufficient for healing.
Area of Science:
- Oral and Maxillofacial Surgery
- Oncology
- Pathology
Background:
- Ameloblastoma and ameloblastic fibroma are benign odontogenic tumors.
- These tumors exhibit destructive local growth and a high recurrence rate.
- Standard surgical treatment involves partial jaw resection.
Observation:
- Tumor tissues possess distinct radiological and histological characteristics.
- Immunohistochemical analysis can identify tumor progression markers.
- Expression of these markers aids in predicting tumor behavior.
Findings:
- Immunohistochemistry allows for personalized surgical strategy selection.
- Our experience indicates that total biopsy with osseous resection of surgical margins can be adequate.
- This approach may facilitate normal bone structure remodeling in select patients.
Implications:
- Tailoring surgical tactics based on immunohistochemical findings can optimize outcomes.
- Less extensive surgical margins may be sufficient in certain ameloblastic tumor cases.
- Further research into predictive markers could refine treatment protocols for odontogenic tumors.
